On a Roll: FDA Calls Sage's Depression Drug a Breakthrough Post author:Sam Post published:February 6, 2018 Post category:BioPharma This is the second Breakthrough Therapy designation granted to Sage since 2016. Source: BioSpace You Might Also Like The Medicines Company To Present Data At On Infectious Disease Portfolio Including Recently Approved Antibiotic VABOMERE(Meropenem And Vaborbactam) September 28, 2017 Why Theranos Could Burn Through All Its Cash by the End of This Year July 4, 2017 Voyager Sinks as Sanofi Genzyme Opts Out of Parkinson's Gene Therapy Program October 30, 2017
The Medicines Company To Present Data At On Infectious Disease Portfolio Including Recently Approved Antibiotic VABOMERE(Meropenem And Vaborbactam) September 28, 2017
